PMC:7534795 / 49750-49999 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T376","span":{"begin":179,"end":187},"obj":"Disease"}],"attributes":[{"id":"A376","pred":"mondo_id","subj":"T376","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"., 2016). An open-label randomized trial has been conducted to test the efficacy of IFN beta-1b, lopinavir–ritonavir and ribavirin for treating patients admitted to hospital with COVID-19 and concluded early triple antiviral therapy was effective in"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T302","span":{"begin":18,"end":23},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"},{"id":"T303","span":{"begin":41,"end":44},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T304","span":{"begin":63,"end":67},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"., 2016). An open-label randomized trial has been conducted to test the efficacy of IFN beta-1b, lopinavir–ritonavir and ribavirin for treating patients admitted to hospital with COVID-19 and concluded early triple antiviral therapy was effective in"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T91487","span":{"begin":18,"end":23},"obj":"Chemical"},{"id":"T32","span":{"begin":88,"end":92},"obj":"Chemical"},{"id":"T59681","span":{"begin":97,"end":106},"obj":"Chemical"},{"id":"T9440","span":{"begin":107,"end":116},"obj":"Chemical"},{"id":"T99302","span":{"begin":121,"end":130},"obj":"Chemical"},{"id":"T36","span":{"begin":215,"end":224},"obj":"Chemical"}],"attributes":[{"id":"A43513","pred":"chebi_id","subj":"T91487","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"},{"id":"A53300","pred":"chebi_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/CHEBI_10545"},{"id":"A34208","pred":"chebi_id","subj":"T59681","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A57584","pred":"chebi_id","subj":"T9440","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A76327","pred":"chebi_id","subj":"T99302","obj":"http://purl.obolibrary.org/obo/CHEBI_63580"},{"id":"A92748","pred":"chebi_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":"., 2016). An open-label randomized trial has been conducted to test the efficacy of IFN beta-1b, lopinavir–ritonavir and ribavirin for treating patients admitted to hospital with COVID-19 and concluded early triple antiviral therapy was effective in"}

{"project":"2_test","denotations":[{"id":"33031856-27400984-84038898","span":{"begin":3,"end":7},"obj":"27400984"}],"text":"., 2016). An open-label randomized trial has been conducted to test the efficacy of IFN beta-1b, lopinavir–ritonavir and ribavirin for treating patients admitted to hospital with COVID-19 and concluded early triple antiviral therapy was effective in"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1476","span":{"begin":144,"end":152},"obj":"Species"},{"id":"1483","span":{"begin":97,"end":116},"obj":"Chemical"},{"id":"1484","span":{"begin":121,"end":130},"obj":"Chemical"},{"id":"1511","span":{"begin":179,"end":187},"obj":"Disease"}],"attributes":[{"id":"A1476","pred":"tao:has_database_id","subj":"1476","obj":"Tax:9606"},{"id":"A1483","pred":"tao:has_database_id","subj":"1483","obj":"MESH:C558899"},{"id":"A1484","pred":"tao:has_database_id","subj":"1484","obj":"MESH:D012254"},{"id":"A1511","pred":"tao:has_database_id","subj":"1511","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"., 2016). An open-label randomized trial has been conducted to test the efficacy of IFN beta-1b, lopinavir–ritonavir and ribavirin for treating patients admitted to hospital with COVID-19 and concluded early triple antiviral therapy was effective in"}